Moreover, some tumor types are characterized by mutations leading to widespread metabolic reprogramming (such as IDH1 mutations in glioma [21] and inactivation of the von Hippel–Lindau tumor suppressor in kidney cancer [22]). This evidence concerns the gene VHL and central nervous system cancer.